Fusidic acid induced acute immunologic thrombocytopenia.

Br J Haematol

Laboratoire d'Immunologie Leuco-plaquettaire, Centre de Transfusion, Hopital Henri Mondor, Créteil, France.

Published: May 1996

Fusidic acid is used in hospitals as second-line therapy for multidrug-resistant staphylococcal infections. We report the first fully documented case of fusidic acid induced thrombocytopenia, in a 48-year-old patient. The thrombocytopenia was abrupt and severe but resolved spontaneously 7 d after drug withdrawal. The thrombocytopenia transiently relapsed 6 d later, when fusidic acid was reintroduced. Haemorrhagic signs were observed, but no severe bleeding occurred. Platelet transfusions failed to increase the platelet count. We detected an IgG platelet antibody in the patient's serum, that specifically recognized platelet glycoprotein IIb/IIIa only in the presence of fusidic acid. Fusidic acid induced thrombocytopenia should be considered as a possible cause for the thrombocytopenia frequently seen in the intensive care setting.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.1996.5211064.xDOI Listing

Publication Analysis

Top Keywords

fusidic acid
24
acid induced
12
induced thrombocytopenia
8
fusidic
6
thrombocytopenia
6
acid
5
induced acute
4
acute immunologic
4
immunologic thrombocytopenia
4
thrombocytopenia fusidic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!